Bit News Ant Group's official Weibo announced that it officially open source the first medical specialty reasoning dataset in China, which will enhance the professionalism of large models in the medical field.
Jointly developed by Ant Group and the urology expert team of Shanghai Renji Hospital, based on the clinical experience of the doctor team, the first Chinese medical specialty Q&A reasoning dataset RJUA-QA was launched by constructing simulated case data. The dataset consists of three parts: training, validation, and testing, and contains 2132 question and answer pairs, each of which is composed of questions written by doctors based on clinical experience, answers provided by experts, and contexts used to help reasoning, covering more than 97.6% of the urology medical population, and can realistically reproduce diagnosis and treatment scenarios.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Ant Group Open source China's first medical specialty reasoning dataset
Bit News Ant Group's official Weibo announced that it officially open source the first medical specialty reasoning dataset in China, which will enhance the professionalism of large models in the medical field.
Jointly developed by Ant Group and the urology expert team of Shanghai Renji Hospital, based on the clinical experience of the doctor team, the first Chinese medical specialty Q&A reasoning dataset RJUA-QA was launched by constructing simulated case data. The dataset consists of three parts: training, validation, and testing, and contains 2132 question and answer pairs, each of which is composed of questions written by doctors based on clinical experience, answers provided by experts, and contexts used to help reasoning, covering more than 97.6% of the urology medical population, and can realistically reproduce diagnosis and treatment scenarios.